tiprankstipranks
Trending News
More News >
Shandong Boan Biotechnology Company., Limited. Class H (HK:6955)
:6955
Hong Kong Market
6955
Shandong Boan Biotechnology Company., Limited. Class H
RESEARCH TOOLSreports
Advertisement

Shandong Boan Biotechnology Company., Limited. Class H (6955) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Shandong Boan Biotechnology Company., Limited. Class H
HK$11.42
HK$7.11B
184.79
22.40%
Alphamab Oncology
HK$13.57
HK$13.22B
51.73
253.39%
0 Buy
0 Hold
0 Sell
Hold
Ascletis Pharma, Inc.
HK$9.40
HK$9.39B
596.30%
1 Buy
1 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$12.79
HK$11.28B
17.30
920.47%
1 Buy
0 Hold
0 Sell
Moderate Buy
Abbisko Cayman Limited
HK$15.37
HK$10.45B
54.91
303.61%
2 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$22.76
HK$9.03B
63.17
217.76%
0 Buy
0 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
11.42
2.09
22.40%
HK:9966
Alphamab Oncology
13.57
9.73
253.39%
HK:1672
Ascletis Pharma, Inc.
9.40
8.05
596.30%
HK:2142
HBM Holdings Ltd.
12.96
11.69
920.47%
HK:2256
Abbisko Cayman Limited
15.66
11.78
303.61%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
23.80
16.31
217.76%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis